Alfametildopa. CC Hidralazina. -Preeclampsia en embarazo anterior. -Periodo intergenésico mayor a 10 años. -Hipertensión arterial crónica. Valdés E, Candia P. Hepatitis aguda por alfa metildopa durante el embarazo. [ Acute hepatitis due to alpha-methyldopa in pregnancy.] Prog Obstet Ginecol Conclusión: los medicamentos acetaminofeno, alfametildopa, labetalol, Hepatotoxicidad; embarazo; enfermedad hepática inducida por medicamentos.

Author: Moshicage Akigul
Country: Fiji
Language: English (Spanish)
Genre: Personal Growth
Published (Last): 26 December 2006
Pages: 75
PDF File Size: 7.86 Mb
ePub File Size: 11.26 Mb
ISBN: 200-9-38540-922-1
Downloads: 44162
Price: Free* [*Free Regsitration Required]
Uploader: Tolabar

The following outcome measures were recorded for each study: There were additionally no significant differences in perinatal outcomes between antihypertensive agents. Women divided into 2 groups—treatment and control No information regarding concealment. Data were extracted and analyzed in Stata version Studies are listed in order of the year they were published.

Aldomet Información Española De la Droga

All randomized controlled trials evaluating antihypertensive treatments for chronic hypertension in pregnancy were included. Prevalence, trends, and outcomes of chronic hypertension: Jonasch E, Haluska FG.

Other systematic reviews have pooled results for chronic and gestational hypertension, but given the different etiology and duration of treatment, there are concerns with this approach. Two studies excluded women with proteinuria, 3344 3 studies included women with proteinuria at study entry, 323543 and the remainder of studies did not specify presence or absence of proteinuria in their methods.

Alfametildopa by Cinthia Cabrera on Prezi

Wichman, Sweden, Prospective, randomized block design, no further details given Participants: A comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy. In 11 patients the presence of IgG1 was showed and also in one case the subclass Meetildopa autoantibodies was identified. Admitted to hospital for hypertension: Where 2 articles published results from the same study, individual pertinent outcomes were extracted from both articles without repetition of data extraction.


This strengthens the finding that antihypertensive agents do not significantly affect perinatal morbidity; agent selection and higher than recommended embrazo are likely to account for the evidence from Butters and colleagues, who published data from a study of 29 participants randomized in the second trimester to atenolol or placebo. Do we really understand immune red cell destruction? Randomized open study, no further details given Participants: Tuimala, Finland, Support Center Support Center.

In high-grade hemolysis patients, it was found a concentration of autoantibodies between 1 and 3 molecules of IgG per erythrocyte, while in low-grade hemolysis patients it behaved between and 1 molecules.

A controlled trial of hypotensive agents in hypertension in pregnancy. Interferon in chronic myeloid leukaemia: Click here for additional data file. Plouin, France, Multiple pregnancy Bradycardia on ECG. Fiddler, UK, Antihypertensive use in pregnancy complicated by chronic hypertension does not increase the risk of stillbirth or neonatal death.

alfa metildopa en el embarazo pdf

ApartadoCP Acta Obstet Gynecol Scand. FDA alerts for all medications. J Pharm Pharm Sci. No treatment diuretics discontinued. Randomized open controlled trial Participants: This is the largest systematic review of the evidence from randomized controlled trials to guide antihypertensive treatment specifically for chronic hypertension in pregnancy.

Moore, UK, Open in a separate window. Lardoux, France, The effects of prophylactic management and therapeutics on hypertensive disease in pregnancy: SeedCStat, 1 Andrew J.

After removal of duplicates, the initial search generated titles and abstracts for review. Doses not specified Gallery, Australia, 52 Study participants had gestational or chronic hypertension. Body mass index was not reported in any of the trials, but 6 studies reported maternal weight at trial entry. A considerable paucity of data exists from randomized controlled trials to guide choice of antihypertensive agent for chronic hypertension in pregnancy.


Stillbirth Birth weight Small for gestational age. The analysis of stillbirth and neonatal death demonstrated a nonsignificant reduction with the use of antihypertensive treatment: Further studies are needed to answer these questions and assess the potential impact of maternal characteristics such as obesity and other medical comorbidities.

Hypertensive disorders of pregnancy: Participants mixed population of gestational and chronic hypertension Allocated randomly to treatment group Open label. Los resultados de la prueba de antiglobulina directa PAD y de la prueba de antiglobulina indirecta PAI previos al tratamiento con IFN ase obtuvieron de los registros del laboratorio.

Comparison of antihypertensive efficacy and perinatal safety of labetalol and methyldopa in the treatment of hypertension embaazo pregnancy: The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records. The gray rectangles represent the risk ratio for each study and are sized in proportion to the weight assigned to the study within the analysis. N Engl J Med. Flowchart of articles identified reporting randomized controlled trials of antihypertensive agents for the treatment of chronic hypertension in pregnancy.